FIXX News and Press, Homology Medicines Inc. From 07/21/20

- Executive with Extensive Rare Disease Expertise in Global Finance and  Commercial Operations - BEDFORD, Mass., July 21, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Jeff Poulton has been appointed to the Boar...

DPW Holdings (NYSEMKT: DPW )   +136%  on introducing a new product line of electric vehicle chargers. More news on: DPW Holdings, Inc., Sonnet BioTherapeutics Holdings, Inc., Volt Information Sciences, Inc., Stocks on the move, , Read more ...

Four names in biotechnology are seeing call-outs from Baird for potentially significant upside, and third-quarter catalysts that could give their stocks a boost. More news on: Homology Medicines, Inc., Dicerna Pharmaceuticals, Inc., Cellular Biomedicine Group, Inc., Healthcare stocks news,...

Quick Take Generation Bio ( GBIO ) intends to raise $126 million from the sale of its common stock in a U.S. IPO, per an amended registration statement . The company is a pre clinical developer of genetic treatments for liver and retinal diseases. GBIO is an ultra early stage biopharma ...

 -  Methods Showed Efficient On-Target Gene Integration with No Unintended DNA Modifications - BEDFORD, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the peer-reviewed publication of methods used...

- Molecular Methods Quantified Precision and Efficiency of Nuclease-Free Gene Editing  for PKU - - Manufacturing Enhancements Led to Improved Productivity, Quality and Scalability of Commercial Process, Confirmed in 2,000L Bioreactor - - Data Highlight Unique Charac...

Homology Medicines (NASDAQ: FIXX ): Q1 GAAP EPS of -$0.78 misses by $0.09 . More news on: Homology Medicines, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

- Progressed the pheNIX Trial for PKU and Added Clinical Sites, Completed Clinical Supply for Phase 1/2 and Began Manufacturing Pivotal Supply - - Executed Commercial Manufacturing Process at 2,000-Liter Bioreactor Scale -  - Implemented Plans to Minimize Potential COVID...

Editor's note: Seeking Alpha is proud to welcome Mariner Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » Summary It&#...

BEDFORD, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today upcoming presentations demonstrating the broad applicability of its in vivo gene therapy and nuclease-free gene editing platform across multiple disea...